Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921

Brivio, E., Pennesi, E., Willemse, M. E., Huitema, A. D. R., Jiang, Y., van Tinteren, H. D. R., van der Velden, V. H. J., Beverloo, B. H., den Boer, M. L., Rammeloo, L. A. J., Hudson, C., Heerema, N., Kowalski, K., Zhao, H., Kuttschreuter, L., Bautista Sirvent, F. J., Bukowinski, A., Rizzari, C., Pollard, J., … Zwaan, C. M. (2024). Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921. Journal of Clinical Oncology, 42(7), 821–831. https://doi.org/10.1200/jco.23.00897
Authors:
Erica Brivio
Edoardo Pennesi
Marieke E. Willemse
Alwin D. R. Huitema
Yilin Jiang
Harm van Tinteren
Vincent H. J. van der Velden
H. Berna Beverloo
Monique L. den Boer
Lukas Rammeloo
Chad A. Hudson
Nyla A. Heerema
Kenneth G. Kowalski
Huadong Zhao
Luke Kuttschreuter
Francisco Bautista
Andrew Bukowinski
Carmelo Rizzari
Jessica A. Pollard
Laura Murillo
Matthew A. Kutny
Sara Zarnegar‐Lumley
Michele S. Redell
Stacy Cooper
Yves Bertrand
Arnaud Petit
Julie Krystal
Markus Metzler
Donna Lancaster
Jean‐Pierre Bourquin
Joseph G. Motwani
Inge M. van der Sluis
Franco Locatelli
Michael Roth
Nobuko Hijiya
C. Michel Zwaan
Affiliated Authors:
Nobuko Hijiya
Publication Type:
Article
Unique ID:
10.1200/jco.23.00897
PMID:
Publication Date:
Data Source:
OpenAlex

Record Created: